Latest in AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say
Sort by
4,089 items
-
AbbVie’s disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say
AbbVie’s “pain” is Bristol Myers Squibb’s “gain,” says Truist Securities analyst Srikripa Devarakonda.Business - MarketWatch - 2 days ago -
Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.Business - MarketWatch - 2 days ago -
AbbVie shares tumble after schizophrenia drug disappoints
US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptomsBusiness - Financial Times - 2 days ago -
Google’s AI-Fueled Results Bode Well for Rivals Amazon and Microsoft
Sales gains in its cloud business point to growing, sustained demand for AI-juiced computing power.Business - Inc. - October 30 -
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.Business - CNBC - October 31 -
Bristol Myers’s stock pops as earnings top estimates and company raises guidance
The company says it “made important strides in the third quarter.”Business - MarketWatch - October 31 -
A promising schizophrenia drug showed mixed results. What does that mean for patients?
Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the researchHealth - ABC News - October 31 -
MLB predictions, picks, best bets: Why pitching matchup bodes well for Aaron Judge, ride with Dodgers' offense
It might be the last day with two games in the 2024 MLB seasonSports - CBS Sports - October 18 -
Belarus arrests well-known analyst as crackdown on opposition continues
Police in Belarus have arrested a well-known political analyst who is the husband of an imprisoned journalist in the country’s relentless crackdown on opposition to authoritarian President ...World - ABC News - October 22 -
Officer apologises for calling Novichok victim 'well-known drug addict'
An inquiry into the death of Dawn Sturgess has begun its third week.Top stories - BBC News - November 4 -
An analyst sees a key catalyst for Wells Fargo early next year — and it's a big reason we own it
Wells Fargo's asset cap may finally be lifted early next year, according to Bank of America analysts.Business - CNBC - 2 days ago -
Wells Fargo touches all-time high as analyst hikes price target to new level
The outperformance of Wells Fargo & Co.’s stock over other big bank stocks continued Tuesday, as its touched an all-time high for the second straight day and a BofA analyst hiked his price target ...Business - MarketWatch - Yesterday -
Potential Cigna buyout of Humana is a ‘when,’ not an ‘if,’ analyst says
Humana’s stock looked to rally Monday. And Mizuho analyst Ann Hynes said she believes a buyout by Cigna Group is likely — it’s just a matter of timing.Business - MarketWatch - October 21 -
Tesla’s robotaxi dreams will start small, these analysts say
Tesla has promised a fleet of Cybercabs by 2026 and millions of the robotaxis at some point in the future, but analysts at Deutsche Bank sought to temper expectations and map out how a Cybercab ...Business - MarketWatch - October 28 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Top stories - NBC News - October 16 -
-
Demonstrators in France praise Gisèle Pélicot's courage in harrowing drug and rape trial
Women and men have demonstrated together in Paris and other French cities in support of Gisèle Pélicot and against sexual violenceWorld - ABC News - October 19 -
Europe falls behind China in playing host to clinical drug trials
Pharmaceutical companies turn to jurisdictions with simpler regulatory regimesBusiness - Financial Times - October 21 -
Over 100 sentenced for drug-related crimes in Belgium’s largest trial
Decryption of Sky ECC messaging system leads to 119 convictionsWorld - Financial Times - October 29 -
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.Business - MarketWatch - November 4 -
EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...World - ABC News - October 31 -
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...Health - ABC News - October 31 -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.Business - CNBC - 22 hours ago -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
A Neuralink Rival Says Its Eye Implant Restored Vision in Blind People
Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.Tech - Wired - October 25 -
Royal Caribbean set for strong quarter, momentum into 2025, says analyst
An analyst points to “ongoing momentum and no signs of consumer softness.”Business - MarketWatch - October 21 -
Reeves’ Budget measures risk hitting ‘working people’, analysts say
Some businesses will struggle with tax rises alongside a higher minimum wage and new labour lawsWorld - Financial Times - October 29 -
JPMorgan may be ‘best in class’ but it’s time to take profits, analyst says
Baird’s David A. George downgrades megabank to underperform because it’s “more than fully priced” at recent levels.Business - MarketWatch - 6 days ago -
Upstart’s stock roars higher. Here’s why analysts say the tide is turning.
Analysts say the AI lender is on a better track is it benefits from an improved interest-rate climate, funding partnerships and “solid” credit trends.Business - MarketWatch - 6 days ago -
Rallying bank stocks have further room to run, analyst says
Hovde’s Feddie Strickland sees additional gains despite rally ‘if history serves as a guide.Business - MarketWatch - 3 days ago -
Dozens jailed in drug smuggling mega-trial: "Your honor, I played, I lost."
The multinational cocaine and cannabis trafficking enterprise was busted after investigators cracked encrypted messaging apps.Top stories - CBS News - October 29 -
Rapper Young Thug pleads guilty to gang, drug and gun charges almost a year after opening statements in trial
Rapper Young Thug pleads guilty to gang, drug and gun charges almost a year after opening statements in trialEntertainment - ABC News - October 31 -
‘Was I drugged and raped? I’ll never know’: partners of accused share fears at Pelicot trial
Some ex-girlfriends of accused men tell court of burden of not knowing if they had been sedated and molested in past . Giving evidence in Avignon’s criminal court, a softly spoken woman in her 30s ...World - The Guardian - 5 days ago -
Cinemark at ‘inflection point,’ well-placed for postpandemic recovery, Benchmark says
Cinemark Holdings Inc.’s better-than-expected third-quarter results this week bode well for the movie-theater chain amid a broader industry rebound, analysts said.Business - MarketWatch - November 1 -
Brother died waiting for lung transplant, says campaigner
A man whose brother died waiting on a double lung transplant says more work is needed to make Cystic Fibrosis drugs available.Top stories - BBC News - October 31 -
Plug Power disappoints with its forecast but says it’s still making progress
The clean-energy company pointed to improvement in operating cash flow and a narrowing loss, though it also cut its revenue outlook for the full year.Business - MarketWatch - 2 days ago -
Firearms officers to get anonymity in shooting cases, says home secretary
Firearms officers to get presumption of anonymity in trials over shootings in line of duty, home secretary says.Top stories - BBC News - October 23
